The COVID-19 pandemic has re-energized the debate on global access to essential medicines.
Access to medicines is a big, complex question. For the Medicines Patent Pool, IP is a critical player in access;...
As the global access debate adapts to the stark inequities exposed by the COVID-19 pandemic, the UN-backed Medicines Patent Pool is emerging as a key player on issues ranging from vaccine tech transfer to making more drugs affordable against the spread of non-communicable diseases like cancer to middle- and low-income countries.
The COVID-19 pandemic has re-energized the debate on global access to essential medicines.
Access to medicines is a big, complex question. For the Medicines Patent Pool, IP is a critical player in access;...
Astellas is transforming its oncology drug discovery using its human-in-the-loop approach which positions AI as a true partner in innovation.
A new AI-based platform is designed to condense months of clinical data analysis into minutes by translating plain language data queries into epidemiologically valid research requests.
Emerging research reveals that biological sex differences may significantly influence Alzheimer’s disease progression and treatment efficacy, underscoring the urgent need for sex-specific analysis in clinical trials and therapeutic development.